REG vs TSHA · P/E 34, rev $1.45B vs $640.7M cap
Regency Centers Corporation (REG) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
REG currently screens at market cap $12.93B and trailing P/E 33.5. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the REG and TSHA stock pages for the full models.
Not investment advice.